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Selection, indications, and Outcomes
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Patients with esophageal atresia (EA) suffer from abnormal and permanent esophageal 
intrinsic and extrinsic innervation that affects severely esophageal motility. The repair of 
EA also results in esophageal shortening that affects distal esophageal sphincter mecha-
nism. Consequently, gastroesophageal reflux (GER) is common in these patients, overall 
approximately half of them suffer from symptomatic reflux. GER in EA patients often 
resists medical therapy and anti-reflux surgery in the form of fundoplication is required. 
In patients with pure and long gap EA, the barrier mechanisms against reflux are even 
more damaged, therefore, most of these patients undergo fundoplication during first 
year of life. Other indications for anti-reflux surgery include recalcitrant anastomotic 
stenoses and apparent life-threatening episodes. In short term, fundoplication alleviates 
symptoms in most patients but recurrences are common occurring in at least one third 
of the patients. Patients with fundoplication wrap failure often require redo surgery, which 
may be complicated and associated with significant morbidity. A safe option in a subset 
of patients with failed anti-reflux surgery appears to be long-term medical treatment with 
proton pump inhibitors.
Keywords: esophageal atresia, fundoplication, anti-reflux surgery, gastroesophageal reflux, anastomotic stricture, 
acute life-threatening events, long-gap atresia
iNTRODUCTiON
The esophagus is not normal following repair of an esophageal atresia (EA). The motility of the 
esophagus is permanently altered, and the esophagus is usually shorter than normal (1–3). The tension 
and abnormal perfusion at the anastomotic site commonly cause stricture formation that requires 
anastomotic dilatations. Pathological gastroesophageal reflux (GER) that is caused by shortening of 
the esophagus and abnormal clearance of esophageal contents due to abnormal motility affects up 
to two thirds of patients with EA (1, 4). Some EA patients experience acute life-threatening events 
(ALTE) that may be associated with proximal extension of GER and also with tracheomalacia that 
commonly accompanies EA. Recurrent respiratory disease has been attributed to GER but evidence 
supporting this is not convincing. Medical therapy, today mainly by proton pump inhibitors (PPI), 
is always the first-line approach for these patients but a significant percentage ultimately undergoes 
surgery in the form of fundoplication. Most pediatric surgeons agree that patients with pure or 
long-gap EA very often require fundoplication to overcome severe GER and anastomotic strictures 
associated with the significant shortening of the esophagus. In the literature, the overall rate of 
fundoplication in patients with EA ranges between 10 and 45% (1, 4, 5).
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iNDiCATiONS FOR FUNDOPLiCATiON  
iN eA
Gastroesophageal Reflux Disease 
(GeRD)
The abnormal esophageal anatomy after repair of EA plays a 
significant role in the etiology of GERD. The esophageal repair 
often causes esophageal shortening that may displace the gastroe-
sophageal junction upward causing an obtuse angle of His. This 
is especially true in patients with long-gap atresia and significant 
anastomotic tension (6).
The esophageal peristalsis that is responsible for esophageal 
clearance is damaged in patients with EA (2, 3). The abnormal 
and ineffective peristalsis does not improve by age as most 
adult patients with repaired EA still show highly abnormal and 
decreased motility in manometric studies (5). The cause of poor 
motility is probably multifactorial. The arrangement of muscular 
layers may be abnormal in EA (1). Both extrinsic and intrinsic 
innervation of the esophageal wall is congenitally deficient (7, 8), 
and there is additional damage that is caused by the extensive 
dissection required for the making of esophago-esophageal 
anastomosis (9).
Symptomatic GER is very common in infants with EA, the 
incidence ranges between 25 and 70% (1). Moreover, unlike GER 
that is not associated with anatomical defects, the proportion 
of significant EA-associated GER tends to increase over time 
(10). GER in infants with EA does not respond well to standard 
methods of management such as thickening of milk and postural 
treatment. Medical treatment may also be unsuccessful although 
most pediatric surgeons routinely treat their EA patients with 
long-term anti-acid medication, today usually with PPI.
Of patients who suffer from significant GERD 30–64% undergo 
fundoplication. Most patients require fundoplication before the 
age of 1 year. There are no generally accepted indications for fun-
doplication in EA patients who suffer from significant GER. The 
usual causes leading to operation are failure of medical treatment 
to control symptoms, failure to thrive, and GER-related refractory 
anastomotic stenosis.
Anastomotic Stricture
Anastomotic strictures requiring dilatation occur in 30–60% 
of EA patients (4, 5, 11). Most strictures respond well to anas-
tomotic dilatations but the choice of the timing of dilatations 
and the number of dilatations remain arbitrary. Most pediatric 
surgeons dilate only symptomatic patients. A small proportion 
of patients who suffer from recalcitrant strictures are commonly 
considered to have significant GER that contributes to refractory 
stenosis formation. Anti-reflux surgery has been suggested to be 
curative in most of these patients (12, 13). However, there are no 
scientifically based definitions for recalcitrant strictures or for the 
timing of surgery. The surgeon’s judgment based on personal or 
institutional experience dictates the timing of surgery. Moreover, 
the efficacy of fundoplication in the management of anastomotic 
strictures remains scientifically unproven. This is especially true 
today in the era of PPI’s that are more or less routinely used in 
patients with EA (14).
Pure/Long-Gap eA
There is a lack of generally accepted definition for long-gap EA. 
Some surgeons consider only pure (type A) or type B atresia with 
proximal fistula as long-gap atresia, some include also “long-gap” 
type C (with distal fistula) atresia. There are also no uniformly 
accepted methods to measure the gap between the esophageal 
ends. It has been clearly shown that long-gap predisposes to 
symptomatic GERD and anastomotic strictures (4, 6, 15), mainly 
because of considerable tension in the anastomosis. The recent 
esophageal lengthening techniques are associated with GERD, 
and fundoplication is required in most patients (16). Anti-reflux 
surgery is considered as a routine and predictable step in the 
management of long-gap EA patients by some surgeons (6, 16, 17), 
others perform fundoplication only in patients with severe symp-
toms and abnormal GERD tests (15).
Acute Life-Threatening events
Acute life-threatening events in the form of cyanotic or dying 
spells occur in some patients with EA. The actual incidence is 
not very well documented but operative treatment is required 
in 5–12% of patients (15, 18). The pathophysiology of ALTE in 
patients with EA is not fully understood. Many of these patients 
have significant tracheomalacia, which is commonly associated 
with GERD. In the literature, ALTE is considered as an absolute 
indication for surgical treatment (19, 20). There is no consensus 
concerning the optimal management of ALTE. In the presence 
of tracheomalacia, some surgeons perform primary aortopexy 
that may be followed by fundoplication (19, 20), some favor 
simultaneous aortopexy and fundoplication (18). Some patients 
may be treated by fundoplication alone if the etiology of ALTE is 
considered to be mainly GERD (21).
Severe Respiratory Disease
Up to 74% of patients with repaired EA suffer from chronic or 
recurrent respiratory symptoms (22). Pulmonary lung function 
test has revealed that 70–90% of EA patients have detectable ven-
tilatory impairment. The defect may be restrictive or obstructive 
or both (22). Moreover, a significant proportion of patients have 
abnormal airway reactivity suggesting susceptibility to asthma. 
It appears, however, that these symptoms are not related to GER 
(23). In addition, fundoplication has not been shown to protect 
from respiratory symptoms or ventilator defects (24). Anti-reflux 
surgery probably has no role in the management of respiratory 
disease in EA patients.
PReOPeRATive wORK-UP
In most cases, the decision to perform fundoplication in patients 
with EA is based on clinical symptoms and findings. Diagnostic 
tests are not always helpful but may support decision-making in 
selected cases. Esophagogastroduodenoscopy is helpful in detect-
ing inflammatory changes in the esophagus of patients with symp-
tomatic GER. Detection of chronic inflammation in symptomatic 
EA patients is considered to support surgical therapy. Endoscopy 
is also useful to assess the severity of anastomotic stricture and 
its response to dilatations. Esophageal pH-metry and impedance 
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pH-metry may be useful adjuncts in surgical decision-making; 
high reflux indices support surgical therapy in a symptomatic 
patient. Esophageal manometry is usually not applicable and is 
anyway almost always pathological in EA patients (22). Gastric 
emptying studies are often abnormal in EA patients and not very 
useful in clinical practice.
wHAT TYPe OF ANTi-ReFLUX SURGeRY 
FOR eA PATieNTS?
The selection of the type of anti-reflux surgery in patients with 
EA has been a matter of debate between pediatric surgeons. 
Partial wraps such as Thal (anterior wrap) or Toupet (posterior 
wrap) operation may be associated with less adverse effect, 
but a higher failure rate (25, 26). On the other hand, complete 
fundoplication such as Nissen operation may result in more 
dysphagia, retching, and gas–bloat (27). This is, however, not 
supported by solid scientific evidence, and some studies have 
not found any differences between complete and partial wraps 
(28). There is absolutely no consensus as to whether partial or 
complete fundoplication should be used in patients with EA. 
There is even less valid scientific evidence to support superior-
ity of either approach in this patient population. Anti-reflux 
surgery may be performed laparoscopically with similar success 
rate than in open surgery, whether with partial or complete 
hiatal wrap (29).
Practically, all patients with EA have abnormal esophageal 
motility (2) that makes them a special group compared to 
otherwise healthy patients requiring fundoplication. They have 
more often esophagitis and higher rate of strictures, and they 
have commonly delayed gastric emptying. The motility problems 
predispose EA patients to postoperative dysphagia and ultimately 
to wrap failure. Some patients may not be able to generate enough 
propulsion to overcome the increased resistance at the esophago-
gastric junction created by the fundoplication and may develop 
respiratory tract problems caused by regurgitation of esophageal 
contents (30). Postoperative dysphagia is typical for laparoscopic 
anti-reflux surgery occurring in one third of the patients (29), but 
it usually disappears within a couple of months.
Some surgeons prefer to use esophageal lengthening pro-
cedures in association with anti-reflux surgery (31). The most 
popular approach is the Collis–Nissen procedure where the 
esophagus is lengthened by stapling the esophagogastric junction 
longitudinally. This operation is mainly used in redo surgery. The 
main problem with this procedure is that it leaves acid secreting 
mucosa in the chest that may result in the development of chronic 
esophagitis and Barrett’s esophagus.
OUTCOMeS OF FUNDOPLiCATiON iN eA
Typically, in most EA patients who have undergone anti-reflux 
surgery the symptoms are initially alleviated (17, 32, 33). 
Unfortunately, the positive effect of fundoplication is transient in 
a significant proportion of patients. Partial wrap may be associ-
ated with fewer symptoms at least after short-term follow-up (25), 
but the scientific basis remains vague.
The wrap failure rates range between 20 and 45% (17, 32–35). 
This is significantly higher rate than in those who undergo 
fundoplication without any underlying anatomic defect (33). 
The wrap failure is usually detected 1.5–2.5  years following 
the primary fundoplication (17). The failure rate appears to be 
similar for both complete and partial wraps or open and lapa-
roscopic approaches. The main problem in the literature is that 
the wrap failure is poorly defined. Most studies define failure 
as a need for reoperation but the actual reasons for reoperation 
are not fully described. The length of follow-up, symptoms, 
investigations, and findings leading to a decision to redo the 
fundoplication are inconsistently characterized in the literature. 
The main reason for these problems is that all studies on the 
fate of fundoplication in EA patients are retrospective. As wrap 
failure is usually defined as need to redo the fundoplication, it 
is likely that the actual failure rate is much higher as patients 
with milder symptoms are most likely managed conservatively. 
Moreover, if all patients would undergo regular and long-term 
endoscopic follow-up, the anatomical failure rate (wrap failure 
and thoracic dislocation of the wrap) would be significantly 
higher than reported.
The causes of wrap failure are likely to be the same anatomical 
and physiological abnormalities that have caused GERD in these 
patients. The short length and poor propulsive activity of the 
repaired esophagus interfere very likely with the persistence of 
the fundoplication (34). The stomach may also be smaller than 
normally, especially in patients who originally have had a pure 
type A EA, which may influence performing of a reliable fun-
doplication. Delayed gastric emptying is a common and persist-
ing finding in EA patients and may contribute to high incidence 
of wrap failures (36).
wHAT ARe THe OPTiONS wHeN 
FUNDOPLiCATiON HAS FAiLeD?
The high incidence of wrap failure following primary fundoplica-
tion in patients with EA raises the question: what to do next? For 
pediatric surgeons, the natural response is to do a redo operation 
to correct the failed wrap (17, 34, 37). Diagnostic work-up is 
required in patients with symptoms of wrap failure. The typical 
tests are contrast X-ray studies, upper gastrointestinal endoscopy, 
and pH-metry. The typical findings at imaging and endoscopy 
are partial or complete unwrapping of the fundoplication or 
dislocation of the wrap partially or completely into the chest. 
pH-metry usually shows a high reflux index compared with 
previous postoperative measurements.
Reoperation following failed wrap is significantly more 
demanding than the primary fundoplication. There is always major 
scarring and adherence of the stomach and wrap area to the spleen, 
liver, and diaphragm. The operative times are longer, and blood 
loss and postoperative complication rates are increased (35, 38).
The literature offers very little data on the outcomes of re do 
fundoplication. Redo fundoplication has been reported to be suc-
cessful in 70–80% of cases overall (35, 38); however, the failure rate 
may be higher than following the primary operation, especially in 
patients with EA (34). This is not unexpected because the factors 
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that have caused the failure of the primary wrap are still present. 
It appears to be imperative to put effort in patient selection for 
redo fundoplication.
An alternative to repeat fundoplication may be maintenance 
therapy with PPI’s. Although prophylactic PPI therapy does not 
reduce the incidence of anastomotic stenosis in infants who have 
undergone repair of EA (39, 40), PPI’s can induce long-term 
remission of erosive esophagitis (41). Marked improvement has 
been noted in symptoms of GERD and severity of esophagitis in 
patients who have received PPI maintenance therapy after failed 
fundoplication (42). Long-term maintenance therapy has also 
been shown to be safe with few adverse effects (43).
Severely symptomatic patients who have undergone one 
or several redo fundoplications and who often do not tolerate 
oral feeding or feedings through gastrostomy are a problematic 
group in EA patients. These patients often suffer from associ-
ated malformations or syndromes and have often undergone 
multiple revisional operations (44). Feeding jejunostomy may 
decrease GER-related symptoms and provides a route for 
enteral feeding at least temporarily for this unfortunate group. 
Another option is esophagogastric disconnection that has been 
used as rescue therapy following failed fundoplications (45). 
Esophagogastric disconnection provides a reliable route for 
gastrostomy feedings and may eliminate GER and its conse-
quences completely.
CONCLUSiON
Fundoplication is frequently required in EA patients, however, 
the indications for fundoplication are not scientifically delineated. 
Partial wraps may be associated with better functional outcome 
but, again, the scientific basis for the statement is vague. This 
clinical equipoise calls for multicenter randomized controlled 
studies to evaluate partial and complete wraps in EA patient 
population. After fundoplication most patients have excellent 
relief of their symptoms. However, wrap failure is much more 
common than in patients without EA and is not related to the 
type of fundoplication. Many patients with wrap failure require 
redo surgery but long-term PPI therapy deserves to be considered 
before subsequent surgical intervention.
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